Estrogen and nerve growth factor-related systems in brain. Effects on basal forebrain cholinergic neurons and implications for learning and memory processes and aging

Annals of the New York Academy of Sciences

Volumn 743, Issue , 1994, Pages 165-196

  Gibbs, R B ^a   Jones, K J ^a   Moorjani, B ^a   Luine, V ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; MUSCARINIC AGENT; MUSCARINIC RECEPTOR BLOCKING AGENT; NERVE GROWTH FACTOR; NERVE GROWTH FACTOR RECEPTOR;

AGING; ALZHEIMER DISEASE; ANIMAL CELL; BRAIN NERVE CELL; BRAIN REGION; CHOLINERGIC ACTIVITY; CHOLINERGIC NERVE CELL; CHOLINERGIC SYSTEM; COGNITION; COGNITIVE DEFECT; CONFERENCE PAPER; DEGENERATIVE DISEASE; ESTROGEN THERAPY; FEMALE; FOREBRAIN; HUMAN; HUMAN CELL; LEARNING; MEMORY; NONHUMAN; RECEPTOR AFFINITY; RECEPTOR BINDING; RECEPTOR UPREGULATION;

ANIMALIA;

EID: 0028607581     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1994.tb55792.x     Document Type: Conference Paper

References (168)

1. 1 BREEDLOVE, S. M. 1992. Sexual dimorphism in the vertebrate nervous system. J Neurosci. 12: 4133–4142.
2. 2 JONES, K. J. 1988. Steroid hormones and neurotrophism: Relationship to nerve injury. Metab. Brain Dis. 3: 1–18.
3. 3 GOULD, E., C. S. WOOLLEY, M. FRANKFURT & B. S. MCEWEN 1990. Gonadal steroids regulate dendritic spine density in hippocampal pyramidel cells in adulthood. Neuroscience 10: 1286–1291.
4. 4 WIELAND, N. G. 1992. Estradiol selectively regulates agonist binding sites on the N‐methyl‐D‐aspartate receptor complex in the CA1 region of the hippocampus. Endocrinology 131: 662–667.
5. 5 VAN HARREN, F., A. VAN HEST & R. P. W. HEINSBROEK 1988. Behavioral differences between male and female rats: Effects of gonadal hormones on learning and memory. Neurosci. Biobehav. Rev. 14: 23–33.
6. 6 WILLIAMS, C. L. & W. H. MECK 1991. The organizational effects of gonadal steroids on sexually dimorphic spatial ability. Psychoneuroendocrinology 16: 155–176.
7. 7 HAMPSON, E. 1990. Variations in sex‐related cognitive abilities across the menstrual cycle. Brain Cognit. 14: 26–43.
8. 8 HAMPSON, E. 1990. Estrogen‐related variations in human spatial and articulatory‐motor skills. Psychoneuroendocrinology 15: 97–111.
9. 9 PHILLIPS, S. M. & B. B. SHERWIN 1992. Effects of estrogen on memory function in surgically menopausal women. Psychoneuroendocrinology 17: 485–495.
10. 10 PHILLIPS, S. M. & B. B. SHERWIN 1992. Variations in memory function and sex steroid hormones across the menstrual cycle. Psychoneuroendocrinology 17: 497–506.
11. 11 GOUCHIE, C. & D. KIMURA 1991. The relationship between testosterone levels and cognitive ability patterns. Psychoneuroendocrinology 16: 323–334.
12. 12 CHRISTIANSEN, K. 1993. Sex hormone‐related variations of cognitive performance in !Kung San hunter‐gatherers of Namibia. Neuropsychobiology 27: 97–107.
13. 13 HACKMAN, B. W. & D. GALBRAITH 1976. Replacement therapy with piperazine oestrone sulphate (‘Harmogen’) and its effect on memory. Curr. Med. Res. Opinion 4: 303–306.
14. 14 BARTUS, R. T., R. L. I. DEAN, B. BEER & A. S. LIPPA 1982. The cholinergic hypothesis of geriatric memory dysfunction. Science 217: 408–417.
15. 15 BENINGER, R. J., B. A. WIRSCHING, K. JHAMANDAS & R. J. BOEGMAN 1989. Animal studies of brain acetylcholine and memory. Arch. Gerontol. Geriatr. (Suppl. 1): 71–89.
16. 16 DRACHMAN, D. A., D. NOFFSINGER, B. J. SAHAKIAN, S. KURDZIEL & P. FLEMING 1980. Aging, memory and the cholinergic system: A study of dichotic listening. Neurobiol. Aging 1: 39–43.
17. 17 DRACHMAN, D. & J. LEAVITT 1974. Human memory and the cholinergic system: A relationship to aging? Arch. Neurol. 30: 113–121.
18. 18 DRACHMAN, D. A. 1977. Memory and cognitive function in man: Does the cholinergic system have a specific role? Neurology 27: 783–790.
19. 19 BARTUS, R. T. & H. R. JOHNSON 1976. Short‐term memory in the rhesus monkey: Disruption from the anti‐cholinergic scopolamine. Pharmacol. Biochem. Behav. 5: 39–46.
20. 20 BARTUS, R. T. 1978. Short‐term memory in the rhesus monkey: Effects of dopamine blockade vs acute haloperidol administration. Pharmacol. Biochem. Behav. 9: 353–357.
21. 21 PENETAR, D. M. & J. H. J. MCDONOUGH 1983. Effects of cholinergic drugs on delayed matching‐to‐sample performance of Rhesus monkeys. Pharmacol. Biochem. Behav. 19: 963–967.
22. 22 AIGNER, T. G. & M. MISHKIN 1986. The effects of physostigmine and scopolamine on recognition memory in monkeys. Behav. Neural Biol. 45: 81–87.
23. 23 AIGNER, T. G., D. L. WALKER & M. MISHKIN 1991. Comparison of the effects of scopolamine administered before and after acquisition in a test of visual recognition memory in monkeys. Behav. Neural Biol. 55: 61–67.
24. 24 WHITEHOUSE, P. J., D. L. PRICE, R. G. STRUBLE, A. W. CLARK, J. T. COYLE & M. R. DELONG 1982. Alzheimer's disease and senile dementia: Loss of neurons in the basal forebrain. Science 215: 1237–1239.
25. 25 PERRY, E. K., R. H. PERRY, G. BLESSED & B. E. TOMLINSON 1977. Necropsy evidence of cholinergic deficits in senile dementia. Lancet 1: 189.
26. 26 DAVIES, P. & A. J. F. MALONEY 1976. Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet 2: 1403.
27. 27 FISCHER, W., W. H. GAGE & A. BJÖRKLUND 1989. Degenerative changes in forebrain cholinergic nuclei correlate with cognitive impairments in aged rats. Eur. J Neurosci. 1: 34–45.
28. 28 FISCHER, W., K. S. CHEN, F. H. GAGE & A. BJÖRKLUND 1991. Progressive decline in spatial learning and integrity of forebrain cholinergic neurons in rats during aging. Neurobiol. Aging 13: 9–23.
29. 29 ALTAVISTA, M. C., P. ROSSI, A. R. BENTIVOGLIO, P. CROCIANI & A. ALBANESE 1990. Aging is associated with a diffuse impairment of forebrain cholinergic neurons. Brain Res. 508: 51–59.
30. 30 STROESSNER‐JOHNSON, H. M., P. R. RAPP & D. G. AMARAL 1992. Cholinergic cell loss and hypertrophy in the medial septal nucleus of the behaviorally characterized aged Rhesus monkey. J Neurosci. 12: 19361944.
31. 31 MESULAM, M. M., E. J. MUFSON & J. ROGERS 1987. Age‐related shrinkage of cortically projecting cholinergic neurons: A selective effect. Ann. Neurol. 22: 31–36.
32. 32 SHERMAN, K. A. & E. FRIEDMAN 1990. Pre‐ and post‐synaptic cholinergic dysfunction in aged rodent brain reegions: New findings and an interpretative review. Int. J Dev. Neurosci. 8: 689–708.
33. 33 KRISTOFIKOVA, Z., J. KASCHKA, H. TEJKALOVA & O. BENESOVA 1992. High‐affinity choline uptake and muscarinic receptors in rat brain during aging. Arch. Gerontol. Geriatr. 15: 87–97.
34. 34 GIBSON, G. E., C. PETERSON & D. J. JENDEN 1981. Brain acetylcholine declines with senescence. Science 213: 674–676.
35. 35 SHERMAN, K. A., J. E. KUSTER, R. L. DEAN, R. T. BARTUS & E. FRIEDMAN 1981. Presynaptic cholinergic mechanisms in brain of aged rats with memory impairments. Neurobiol. Aging 2: 99–104.
36. 36 SIMS, N. R., K. L. MAREK, D. M. BOWEN & A. N. DAVISON 1982. Production of [ 14 C]acetylcholine and [ 14 C]carbon dioxide from [U‐ 14 C]glucose in tissue prisms from aging rat brain. J. Neurochem. 26: 127–139.
37. 37 TAKEI, N., I. NIHONMATSU & H. KAWAMURA 1989. Age‐related decline of acetylcholinesterase release evoked by depolarizing stimulation. Neurosci. Lett. 101: 182–186.
38. 38 WU, C. F., R. BERTORELLI, M. SACCONI, G. PEPEU & S. CONSOLO 1988. Decrease of brain acetyolcholine release in aging freely‐moving rats detected by microdialysis. Neurobiol. Aging 9.
39. 39 ARAUJO, D. M., P. A. LAPCHAK, M. J. MEANEY, B. COLLIER & R. QUIRION 1990. Effects of aging on nicotinic and muscarinic autoreceptor function in the rat brain: Relationship to presynaptic cholinergic markers and binding sites. J Neurosci. 10: 3069–3078.
40. 40 TAYLOR, L. & W. H. GRIFFITH 1993. Age‐related decline in cholinergic synaptic transmission in hippocampus. Neurobiol. Aging 14: 509–515.
41. 41 KESNER, R. P., T. ADELSTEIN & K. A. CRUTCHER 1987. Rats with nucleus basalis magnocellularis lesions mimic nmemonic symptomatology observed in patients with dementia of the Alzheimer's type. Behav. Neurosci. 101: 451–456.
42. 42 PERRY, E. K., B. E. TOMLINSON, G. BLESSED, K. BERGMANN, P. H. GIBSON & R. H. PERRY 1978. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. Br. Med. J. 2: 1457.
43. 43 COYLE, J. T., D. L. PRICE & M. R. DELONG 1983. Alzheimer's disease: A disorder of cortical cholinergic innervation. Science 219: 1184–1190.
44. 44 DEKKER, J. A. M., D. J. CONNOR & L. J. THAL 1991. The role of cholinergic projections from the nucleus basalis in memory. Neurosci. Biobehav. Rev. 15: 299–317.
45. 45 MCGURK, S. R., E. D. LEVIN & L. L. BUTCHER 1991. Impairment of radialarm maze performance in rats following lesions involving the cholinergic medial pathway: Reversal by arecoline and differential effects of muscarinic and nicotinic antagonists. Neuroscience 44: 137–147.
46. 46 MATSUOKA, N., N. MAEDA, Y. OHKUBO & I. YAMAGUCHI 1991. Differential effects of physostigmine and pilocarpine on the spatial memory deficits produced by two septo‐hippocampal deafferentiations in rats. Brain Res. 559: 223–240.
47. 47 MURRAY, C. L. & H. C. FIBIGER 1986. Pilocarpine and physostigmine attenuate spatial memory impairments produced by lesions of the nucleus basalis magnocellularis. Behav. Neurocsci. 100: 23–32.
48. 48 MURRAY, C. L. & H. C. FIBIGER 1985. Learning and memory deficits after lesions of the nucleus basalis magnocellularis: Reversal by physostigmine. Neuroscience 14: 1025–1032.
49. 49 DUNNETT, S. B., I. Q. WHISHAW, G. H. JONES & S. T. GUNCH 1987. Behavioral, biochemical and histochemical effects of different neurotoxic amino acids injected into the nucleus basalis magnocellularis of rats. Neuroscience 20: 653–669.
50. 50 ETHERINGTON, R., G. MITTLEMAN & T. W. ROBBINS 1987. Comparative effects of nucleus basalis and fimbria‐fornix lesions on delayed matching and alternation tests of memory. Neurosci. Res. Commun. 1: 135–143.
51. 51 KISH, S. J., Y. ROBITAILLE, M. EL‐AWAR, J. H. DECK, J. SIMMONS, L. SCHUT, L. J. CHANG, L. DISTEFANO & F. DISTEFANO 1989. Non‐Alzheimer‐type pattern of brain choline acetyltransferase reduction in dominantly inherited olivopontocerebellar atrophy. Ann. Neurol. 26: 362–367.
52. 52 NILSSON, O. G., G. LEANZA, C. ROSENBLAD, D. A. LAPPI, R. G. WILEY & A. BJÖRKLUND 1992. Spatial learning impairments in rats with selective immunolesion of the forebrain cholinergic system. NeuroReport 3: 1005–1008.
53. 53 KUMAR, V. & M. CALACHE 1991. Treatment of Alzheimer's disease with cholinergic drugs. Int. J Clin. Pharmacol. Ther. Toxicol. 29: 23–37.
54. 54 SITARAM, N., H. WEINGARTNER, E. D. CAINE & J. C. GILLIN 1978. Choline: Selective enhancement of serial learning and encoding of low imagery words in man. Life Sci. 22: 1555–1560.
55. 55 BARTUS, R. J., R. L. DEAN & B. BEER 1983. An evaluation of drugs for improving memory in aged monkeys: Implications for clinical trials in humans. Psychopharmacol. Bull. 19: 168–184.
56. 56 LINDSAY, R. M., R. F. ALDERSON, B. FRIEDMAN & C. H. IP 1991. The neurotrophin family of NGF‐related neurotrophic factors. Restorative Neurol. & Neurosci. 2: 211–220.
57. 57 TERRY, A. V. J., W. J. JACKSON & J. J. BUCCAFUSCO 1993. Effects of concomitant cholinergic and adrenergic stimulation on learning and memory performance by young and aged monkeys. Cerebral Cortex 3: 304–312.
58. 58 FINE, A., S. B. DUNNETT, A. BJÖRKLUND & S. D. IVERSEN 1985. Cholinergic ventral forebrain grafts into the neocortex improve passive avoidance memory in a rat model of Alzheimer's disease. Proc. Nat. Acad. Sci. USA 82: 5227–5230.
59. 59 RIDLEY, R. M., S. GRIBBLE, B. CLARK, H. F. BAKER & A. FINE 1992. Restoration of learning ability in fornix‐transected monkeys after fetal basal forebrain but not fetal hippocampal tissue transplantation. Neuroscience 48: 779–792.
60. 60 WELNER, S. A., S. B. DUNNETT, J. D. SALAMONE, B. MACLEAN & S. D. IVERSEN 1988. Transplantation of embryonic ventral forebrain grafts to the neocortex of rats with bilateral lesions of nucleus basalis magnocellularis ameliorates a lesion‐induced deficit in spatial memory. Brain Res. 463: 192–197.
61. 61 NILSSON, O. G., M. L. SHAPIRO, F. H. GAGE, D. S. OLTON & A. BJÖRKLUND 1987. Spatial learning and memory following fimbria‐fornix transection and grafting of fetal septal neurons to the hippocampus. Exp. Brain Res. 67: 195–215.
62. 62 DUNNETT, S. B., W. C. LOW, S. D. IVERSEN, U. STENEVI & A. BJÖRKLUND 1982. Septal transplants restore maze learning in rats with fimbria‐fornix lesions. Brain Res. 251: 335–348.
63. 63 DANILOFF, J. K., R. P. BODONY, W. C. LOW & J. WELLS 1985. Cross‐species embryonic septal transplants: Restoration of conditioned learning behavior. Brain Res. 346: 176–180.
64. 64 GAGE, F. H., A. BJÖRKLUND, U. STENEVI, S. B. DUNNETT & P. A. T. KELLY 1984. Intrahippocampal septal grafts ameliorate learning impairments in aged rats. Science 225: 533–536.
65. 65 GAGE, F. H. & A. BJÖRKLUND 1986. Cholinergic septal grafts into the hippocampal formation improve spatial learning and memory in aged rats by an atropine‐sensitive mechanism. J Neurosci. 6: 2837–2847.
66. 66 SCHENK, F., B. CONTANT & P. WERFFELI 1990. Intrahippocampal cholinergic grafts in aged rats compensate impairments in a radial maze and in a place learning task. Exp. Brain Res. 82: 641–650.
67. 67 EIDE, F. F., D. H. LOWENSTEIN & L. F. REICHARDT 1993. Neurotrophins and their receptors—current concepts and implications for neurologic disease. Exp. Neurol. 121: 200–214.
68. 68 LEVI‐MONTALCINI, R. 1952. Effects of mouse tumor transplantation on the nervous system. Ann. N. Y. Acad. Sci. 55: 330–343.
69. 69 CARROLL, S. L., I. SILOS‐SANTIAGO, S. E. FRESE, K. G. RUIT, J. MILBRANDT & W. D. SNIDER 1992. Dorsal root ganglion neurons expressing trk are selectively sensitive to NGF deprivation in utero. Neuron 9: 779–788.
70. 70 THOENEN, H., C. BRANDTLOW & R. HEUMANN 1987. The physiological function of nerve growth factor in the central nervous system: Comparison with the periphery. Rev. Physiol. Biochem. Pharmacol. 109: 145–178.
71. 71 LEWIN, G. R., A. M. RITTER & L. M. MENDELL 1992. On the role of nerve growth factor in the development of myelinated nociceptors. J Neurosci. 12: 1896–1905.
72. 72 DIAMOND, J., M. COUGHLIN, L. MACINTYRE, M. HOLMES & B. VISHEAU 1987. Evidence that endogenous β nerve growth factor is responsible for the collateral sprouting, but not the regeneration, of nociceptive axons in adult rats. Proc. Nat. Acad. Sci. USA 84: 6596–6600.
73. 73 DIAMOND, J., M. HOLMES & M. COUGHLIN 1992. Endogenous NGF and nerve impulses regulate the collateral sprouting of sensory axons in the skin of the adult rat. J Neurosci. 12: 1454–1466.
74. 74 KORSCHING, S., G. AUBURGER, R. HEUMANN, J. SCOTT & H. THOENEN 1985. Levels of nerve growth factor and its mRNA in the central nervous system of the rat correlate with cholinergic innervation. EMBO J. 4: 1389–1393.
75. 75 SHELTON, D. L. & L. F. REICHARDT 1986. Studies on the expression of the β nerve growth factor (NGF) gene in the central nervous system: Level and regional distribution of NGF mRNA suggest that NGF functions as a trophic factor for several distinct pouplations of neurons. Proc. Nat. Acad. Sci. USA 83: 2714–2718.
76. 76 WHITTEMORE, S. R., T. EBENDAL, L. LÄRKFORS, L. OLSON, Å. SEIGER, I. STROMBERG & H. PERRSON 1986. Developmental and regional expression of β nerve growth factor messenger RNA and protein in the rat central nervous system. Proc. Nat. Acad. Sci. USA 83: 817–821.
77. 77 SCHWEITZER, J. B. 1987. Nerve growth factor receptor‐mediated transport from cerebrospinal fluid to basal forebrain neurons. Brain Res. 423: 309–317.
78. 78 DAWBARN, D., S. J. ALLEN & F. M. SEMENENKO 1988. Coexistence of choline acetyltransferase and nerve growth factor receptors in the rat basal forebrain. Neurosci. Lett. 94: 138–144.
79. 79 WOOLF, N. J., E. GOULD & L. L. BUTCHER 1989. Nerve growth factor receptor is associated with cholinergic neurons of the basal forebrain but not the pontomesencephalon. Neuroscience 30: 143–152.
80. 80 GIBBS, R. B. & D. W. PFAFF 1994. In situ hybridization detection of trkA mRNA in brain: Distribution, co‐localization with p75 NGFR and up‐regulation by nerve growth factor. J. Comp. Neurol. 341: 324–339.
81. 81 HOLTZMAN, D. M., Y. LI, L. F. PARADA, S. KINSMAN, C.‐K. CHEN, J. S. VALLETTA, J. ZHOU, J. B. LONG & W. C. MOBLEY 1992. pl40 trk mRNA marks NGF‐responsive forebrain neurons: Evidence that trk gene expression is induced by NGF. Neuron 9: 465–478.
82. 82 CAVICCHIOLI, L., T. P. FLANIGAN, J. G. DICKSON, G. VANTINI, R. D. TOSO, M. FUSCO, F. S. WALSH & A. LEON 1991. Choline acetyltransferase messenger RNA expression in developing and adult rat brain: Regulation by nerve growth factor. Mol. Brain Res. 9: 319–325.
83. 83 LORENZI, M. V., B. KNUSEL, F. HEFTI & W. L. STRAUSS 1992. Nerve growth factor regulation of choline acetyltransferase gene expression in rat embryo basal forebrain. Neurosci. Lett. 140: 185–188.
84. 84 DEKKER, A. J. & L. J. THAL 1992. Effect of delayed treatment with nerve growth factor on choline acetyltransferase activity in the cortex of rats with lesions of the nucleus basalis magnocellularis: Dose requirements. Brain Res. 584: 55–63.
85. 85 FUSCO, M., B. ODERFELD‐NOWAK, G. VANTINI, N. SCHIAVO, M. GRADKOWSKA, M. ZAREMBA & A. LEON 1989. Nerve growth factor affects uninjured, adult rat septohippocampal cholinergic neurons. Neuroscience 33: 45–52.
86. 86 GNAHN, H., F. HEFTI, R. HEUMANN, M. SCHWAB & H. THOENEN 1983. NGF‐mediated increase of choline acetyltransferase (ChAT) in the neonatal forebrain: Evidence for a physiological role of NGF in the brain? Dev. Brain Res. 9: 45–52.
87. 87 VANTINI, G., N. SCHIAVO, A. DI MARTINO, P. POLATO, C. TRIBAN, L. CALLEGARO, G. TOFFANO & A. LEON 1989. Evidence for a physiological role of nerve growth factor in the central nervous system of neonatal rats. Neuron 3: 267–273.
88. 88 HEFTI, F. 1986. Nerve growth factor promotes survival of septal cholinergic neurons after fimbrial transections. J Neurosci. 6: 2155–2162.
89. 89 KROMER, L. F. 1987. Nerve growth factor treatment after brain injury prevents neuronal death. Science 235: 214–216.
90. 90 WILLIAMS, L. R., S. VARON, G. M. PETERSON, K. WICTORIN, W. FISCHER, A. BJÖRKLUND & F. H. GAGE 1986. Continuous infusion of nerve growth factor prevents basal forebrain neuronal death after fimbria fornix transection. Proc. Nat. Acad. Sci. USA 83: 9231–9235.
91. 91 ROSENBERG, M. B., T. FRIEDMAN, R. C. ROBERTSON, M. TUSZYNSKI, J. A. WOLFF, X. O. BREAKFIELD & F. H. GAGE 1988. Grafting genetically modified cells to the damaged brain: Restorative effects of NGF expression. Science 242: 1575–1578.
92. 92 PICCARDO, P., D. MAYSINGER & A. C. CUELLO 1992. Recovery of nucleus basalis cholinergic neurons by grafting NGF secretor fibroblasts. NeuroReport 3: 353–356.
93. 93 RYLETT, R. J., S. GODDARD, B. M. SCHMIDT & L. R. WILLIAMS 1993. Acetylcholine synthesis and release following continuous intracerebral administration of NGF in adult and aged Fischer‐344 rats. J Neurosci. 13: 3956–3963.
94. 94 ARAUJO, D. M., P. A. LAPCHAK & F. HEFTI 1993. Effects of chronic basic fibroblast growth factor administration to rats with partial fimbrial transections on presynaptic cholinergic parameters and muscarinic receptors in the hippocampus: Comparison with nerve growth factor. J Neurochem. 61: 899–910.
95. 95 MAYSINGER, D., M. HERRERA‐MARSCHITZ, U. UNGERSTEDT & A. C. CUELLO 1990. Release of acetylcholine from cerebral cortex in vivo: Effects of NGF and GM 1. Eur. J. Pharmacol. 83: 935.
96. 96 LAPCHAK, P. A. & F. HEFTI 1991. Effect of recombinant human nerve growth factor on presynaptic cholinergic function in rat hippocampal slices following partial septohippocampal lesions: Measures of [ 3 H]acetylcholine synthesis, [ 3 H]acetylcholine release and choline acetyltransferase activity. Neuroscience 42: 639–649.
97. 97 GIBBS, R. B., M. V. CHAO & D. W. PFAFF 1991. Effects of fimbria‐fornix and angular bundle transection on expression of the p75 NGFR mRNA by cells in the medial septum and diagonal band of Broca: Correlations with cell survival, synaptic reorganization and sprouting. Mol. Brain Res. 11: 207–219.
98. 98 CHAO, M. V., M. A. BOTHWELL, M. A. ROSS, H. KOPROWSKI, A. A. LANAHAN, C. R. BUCK & A. SEHGAL 1986. Gene transfer and molecular cloning of the human NGF receptor. Science 232: 518–521.
99. 99 JOHNSON, D., A. LANAHAN, C. R. BUCK, A. SEHGAL, C. MORGAN, E. MERCER, M. BOTHWELI, & M. V. CHAO 1986. Expression and structure of the human NGF receptor. Cell 47: 545–554.
100. 100 RODRIGUEZ‐TEBAR, A., G. DECHANT & Y.‐A. BARDE 1990. Binding of brain‐derived neurotrophic factor to the nerve growth factor receptor. Neuron 4: 487–492.
101. 101 SQUINTO, S. P., T. N. STITT, T. H. ALDRICH, S. DAVIS, S. M. BIANCO, C. RADZIEWIEWSKI, D. J. GLASS, P. MASIAKOWSKI, M. E. FURTII, D. M. VALENZUELA, P. S. DISTEFANO & G. D. YANCOPOULOS 1991. trkB encodes a functional receptor for brain‐derived neurotrophic factor and neurotrophin‐3 but not nerve growth factor. Cell 65: 885–893.
102. 102 HEMPSTEAD, B. L., D. MARTIN‐ZANCA, D. R. KAPLAN & M. V. CHAO 1991. High affinity NGF binding requires co‐expression of the trk proto‐oncogene and the low affinity NGF receptor. Nature 350: 678–683.
103. 103 BARBACID, M., F. LAMBALLE, D. PULIDO & R. KLEIN 1991. The trk family of tyrosine kinase receptors. Biochem. Biophys. Acta 1072: 115–127.
104. 104 KAPLAN, D. R., B. HEMPSTEAD, D. MARTIN‐ZANCA, M. V. CHAO & L. F. PARADA 1991. The trk proto‐oncogene product: A signal transducing receptor for nerve growth factor. Science 252: 554–558.
105. 105 MARTIN‐ZANCA, D., R. OSKAM, G. MITRA, T. COPELAND & M. BARBACID 1989. Molecular and biochemical characterization of the human trk protooncogene. Mol. Cell. Biol. 9: 24–33.
106. 106 RAFFIONI, S. & R. A. BRADSHAW 1993. The receptors for nerve growth factor and other neurotrophins. Ann. Rev. Biochem. 62: 823–850.
107. 107 HIGGINS, G. A., S. KOH, K. S. CHEN & F. H. GAGE 1989. NGF induction of NGF receptor gene expression and cholinergic hypertrophy within the basal forebrain of the adult rat. Neuron 3: 247–256.
108. 108 FUSCO, M., M. BENTIVOGLIO, G. VANTINI, D. GUIDOLIN, P. POLATO & A. LEON 1991. Nerve growth factor receptor‐immunoreactive fibres innervate the reticular thalamic nucleus: Modulation by nerve growth factor treatment in neonate, adult and aged rats. Eur. J Neurosci. 3: 1008–1015.
109. 109 FUSCO, M., P. POLATO, G. BANTINI, L. CAVICCHIOLI, M. BENTIVOGLIO & A. LEON 1991. Nerve growth factor differentially modulates the expression of its receptor within the CNS. J Comp. Neurol. 312: 477–491.
110. 110 VERGE, V. M. K., J.‐P. MERLIO, J. GRONDIN, P. ERNFORS, H. PERRSON, R. J. RIOPELLE, T. HOKFELT & P. M. RICHARDSON 1992. Colocalization of NGF binding sites, trk mRNA, and low‐affinity NGF receptor mRNA in primary sensory neurons: Response to injury and infusion of NGF. J Neurosci. 12: 4011–4022.
111. 111 KAPLAN, D. R., D. MARTIN‐ZANCA & L. F. PARADA 1991. Tyrosine phosphorylation and tyrosine kinase activity of the trk proto‐oncogene product induced by NGF. Nature 350: 158–160.
112. 112 KLEIN, R., S. JING, V. NANDURI, E. O'ROURKE & M. BARBACID 1991. The trk proto‐oncogene encodes a receptor for nerve growth factor. Cell 65: 189–197.
113. 113 JING, S., P. TAPLEY & M. BARBACID 1992. Nerve growth factor mediates signal transduction through trk homodimer receptors. Neuron 9: 1067–1079.
114. 114 KNÜSEL, B. & F. HEFTI 1992. K‐252 compounds: Modulators of neurotrophin signal transduction. J Neurochem. 59: 1987–1996.
115. 115 NYE, S. H., S. P. SQUINTO, D. J. GLASS, T. N. STITT, P. HANTZOPOULOS, M. J. MACCHI, N. S. LINDSAY, N. Y. IP & G. D. YANCOPOULOS 1992. K‐252a and staurosporine selectively block autophosphorylation of neuro‐trophin receptors and neurotrophin‐mediated responses. Molec. Biol. Cell 3: 677–686.
116. 116 OHMICHI, M., S. J. DECKER, L. PANG & A. R. SALTIEL 1992. Inhibition of the cellular actions of nerve growth factor by staurosporine and K252A results from the attenuation of the activity of the trk tyrosine kinase. Biochemistry 31: 4034–4039.
117. 117 SOLTOFF, S. P., S. L. RABIN, L. C. CANTLEY & D. R. KAPLAN 1992. Nerve growth factor promotes the activation of phosphatidylinositol 3‐kinase and its association with the trk tyrosine kinase. J Biol. Chem. 267: 17472–17477.
118. 118 OHMICHI, M., S. J. DECKER & A. R. SALTIEL 1992. Activation of phosphati‐dylinositol‐3 kinase by nerve growth factor involves indirect coupling of the trk proto‐oncogene with src homology 2 domains. Neuron 9: 769–777.
119. 119 OBERMEIER, A., H. HALFTER, K.‐H. WEISMULLER, G. JUNG & J. SCHLESSINGER 1993. Tyrosine 785 is a major determinant of Trk‐substrate interations. EMBO J. 12: 933–941.
120. 120 LI, B.‐Q., D. KAPLAN, H.‐F. KUNG & T. KAMATA 1992. Nerve growth factor stimulation of the ras‐guanine nucleotide exchange factor and GAP activities. Science 256: 1456–1459.
121. 121 SZEBERENYI, J., H. CAI & G. M. COOPER 1990. Mol. Cell. Biol. 10: 5324–5332.
122. 122 SZEBERENYI, J., P. ERHARDT, H. CAI & G. M. COOPER 1992. Role of Ras in signal transduction from the nerve growth factor receptor: Relationship to protein kinase C, calcium and cyclic AMP. Oncogene 7: 2105–2113.
123. 123 D'ARCANGELO, G. & S. HALEGOUA 1993. A branched signaling pathway for nerve growth factor is revealed by src‐, ras, and raf‐mediated gene inductions. Mol. Cell. Biol. 13: 3146–3155.
124. 124 LLOYD, E. D. & M. W. WOOTEN 1992. pp 42/44 MAP kinase is a component of the neurogenic pathway utilized by nerve growth factor in PC12 cells. J. Neurochem. 59: 1099–1109.
125. 125 GOMEZ, N. & P. COHEN 1991. Dissection of the protein kinase cascade by which nerve growth factor activates MAP kinases. Nature 353:.
126. 126 BARBACID, M. 1993. Nerve growth factor: A tale of two receptors. Oncogene 8: 2033–2042.
127. 127 BERG, M. M., D. W. STERNBERG, B. L. HEMPSTEAD & M. V. CHAO 1991. The low‐affinity p75 nerve growth factor (NGF) receptor mediates NGF‐induced tyrosine phosphorylation. Proc. Nat. Acad. Sci. USA 88: 7106–7110.
128. 128 BATTLEMAN, D. S., A. I. GELLER & M. V. CHAO 1993. HSV‐1 vector‐mediated gene transfer of the human nerve growth factor receptor p75 hNGFR defines high‐affinity NGF binding. J. Neurosci. 13: 941–951.
129. 129 BENEDETTI, M., A. LEVI & M. V. CHAO 1993. Differential expression of nerve growth factor receptors leads to altered binding affinity and neurotrophin responsiveness. Proc. Nat. Acad. Sci. USA 90: 7859–7863.
130. 130 YAN, H., J. SCHLESSINGER & M. V. CHAO 1991. Chimeric NGF‐EGF receptors define domains responsible for neuronal differentiation. Science 252: 561–563.
131. 131 LEE, K.‐F., E. LI, J. HUBER, S. C. LANDIS, A. H. SHARPE, M. V. CHAO & R. JAENISCH 1992. Targeted mutation of the gene encoding the low affinity NGF receptor p75 lead to deficits in the peripheral sensory nervous system. Cell 69: 737–749.
132. 132 DAVIES, A. M., K.‐F. LEE & R. JAENISCH 1993. p75‐deficient trigeminal sensory neurons have an altered response to NGF but not to other neurotrophins. Neuron 11: 565–574.
133. 133 ALBERCH, J., E. PEREZ‐NAVARRO, E. ARENAS & J. MARSAL 1991. Involvement of nerve growth factor and its receptor in the regulation of the cholinergic function in aged rats. J Neurochem. 57: 1483–1487.
134. 134 MARKRAM, H. & M. SEGAL 1990. Regional changes in NGF receptor immunohistochemical labeling in the septum of the aged rat. Neurobiol. Aging. 11: 481–484.
135. 135 KERWIN, J., C. MORRIS, A. OAKLEY, R. PERRY & E. PERRY 1991. Distribution of nerve growth factor receptor immunoreactivity in the human hippocampus. Neurosci. Lett. 121: 178–182.
136. 136 KOH, S., P. CHANG, T. J. COLLIER & R. LOY 1989. Loss of NGF receptor immunoreactivity in basal forebrain neurons of aged rats: Correlation with spatial memory impairment. Brain Res. 498: 397–404.
137. 137 FISCHER, W., A. BJORKLUND, K. CHEN & F. H. GAGE 1991. NGF improves spatial memory in aged rodents as a function of age. J Neurosci. 11: 1889–1906.
138. 138 STRADA, O., E. C. HIRSCH, F. JAVOY‐AGID, S. LEHERICY, M. RUBERG, J. J. HAUW & Y. AGID 1992. Does loss of nerve growth factor receptors precede loss of cholinergic neurons in Alzheimer's disease? An autoradiographic study in the human striatum and basasl forebrain. J Neurosci. 12: 4766–4774.
139. 139 KERWIN, J. M., C. M. MORRIS, R. H. PERRY & E. K. PERRY 1992. Hippocampal nerve growth factor receptor immunoreactivity in patients with Alzheimer's disease and Parkinson's disease. Neurosci. Lett. 143: 101–104.
140. 140 HELLWEG, R., W. FISCHER, C. HOCK, F. H. GAGE, A. BJORKLUND & H. THOENEN 1990. Nerve growth factor levels and choline acetyltransferase activity in the brain of aged rats with spatial memory impairments. Brain Res. 537: 123–130.
141. 141 KATOH‐SEMBA, R., R. SEMBA, S. KASHIWAMATA & K. KATO 1991. Elevated concentrations of beta‐nerve growth factor in selected tissues from senescence‐accelerated mice (SAM‐P/8). Mech. Aging Dev. 59: 163–175.
142. 142 LÄRKFORS, L., T. EBENDAL, S. R. WHITTEMORE, H. PERSSON, B. HOFFER & L. OLSON 1987. Decreased levels of nerve growth factor (NGF) and its messenger RNA in the aged rat brain. Mol. Brain Res. 3: 55–60.
143. 143 CRUTCHER, K. A. & J. WEINGARTNER 1991. Hippocampal NGF levels are not reduced in the aged Fischer 344 rat. Neurobiol. Aging 12: 449–454.
144. 144 WILLIAMS, L. R., R. J. RYLETT, H. C. MOISES & A. H. TANG 1991. Exogenous NGF affects cholinergic transmitter function and Y‐maze behavior in aged Fischer 344 male rats. Can. J Neurol. Sci. 18: 403–407.
145. 145 GIBBS, R. B. & D. W. PFAFF 1992. Effects of estrogen and fimbria/fornix transection on p75 NGFR and ChAT expression in the medial septum and diagonal band of Broca. Exp. Neurol. 116: 23–39.
146. 146 LUINE, V. N. & B. S. MCEWEN 1983. Sex differences in cholinergic enzymes of diagonal band nuclei in the rat preoptic area. Neuroendocrinology 36: 475–482.
147. 147 LUINE, V. N. 1985. Estradiol increases choline acetyltransferase activity in specific basal forebrain nuclei and projection areas of female rats. Exp. Neurol. 89: 484–490.
148. 148 HONJO, J., T. TAMURA, Y. MATSUMOTO, M. KAWATA, Y. OGINO, K. TANAKA, T. YAMAMOTO, S. UEDA & H. OKADO 1992. Estrogen as a growth factor to central nervous cells. J Steroid Biochem. 41: 633–635.
149. 149 TORAN‐ALLERAND, D., R. C. MIRANDA, W. D. L. BENTHAM, F. SOHRABJI, T. J. BROWN, R. B. HOCHBERG & N J. MACLUSKY 1992. Estrogen receptors colocalize with low‐affinity nerve growth factor receptors in cholinergic neurons of the basal forebrain. Proc. Nat. Acad. Sci. USA 89: 4668–4672.
150. 150 LOY, R. & R. A. SHELDON 1987. Sexually dimorphic development of cholinergic enzymes in the rat septohippocampal system. Dev. Brain Res. 34: 156–160.
151. 151 KORNACK, D. R., B. LU & I. B. BLACK 1991. Sexually dimorphic expression of the NGF receptor gene in the developing rat brain. Brain Res. 542: 171–174.
152. 152 FISCHER, W. & A. BJÖRKLUND 1991. Loss of AChE‐ and NGFr‐labeling precedes neuronal death of axotomized septal‐diagonal band neurons: reversal by intraventricular NGF infusion. Exp. Neurol. 113: 93–108.
153. 153 SPRINGER, J. E., S. KOH, M. W. TAYRIEN & R. LOY 1987. Basal forebrain magnocellular neurons stain for nerve growth factor receptor: Correlation with cholinergic cell bodies and effects of axotomy. J Neurosci. Res. 17: 111–118.
154. 154 GIBBS, R. B., D.‐H. WU, L. HERSH & D. W. PFAFF 1994. Effects of estrogen on relative levels of ChAT, trkA, and NGF mRNAs in the rat forebrain and hippocampal formation. Exp. Neurol. 129 (1): 70–80.
155. 155 FILLIT, H., H. WEINREB, I. CHOLST, V. LUINE, B. MCEWEN, R. AMADOR & J. ZABRISKIE 1986. Observations in a preliminmary open trial of estradiol therapy for senile dementia‐Alzheimer's type. Psychoneuroendocrinology 11: 337–345.
156. 156 HONJO, H., Y. OGINO, K. NAITOH, M. URABE, J. KITAWAKI, J. YASUDA, T. YAMMAMOTO, S. ISHIHARA, H. OKADA, T. YONEZAWA, K. HAYASHI & T. NAMBARA 1989. In vivo efects by estrone sulfate on the central nervous system‐senile dementia (Alzheimer's type). J Steroid Biochem. 34: 521–525.
157. 157 PAGANINI‐HILL, A., J. G. BUCKWALTER, C. G. LOGAN & V. W. HENDERSEN 1993. Estrogen replacement and Alzheimer's disease in women. Soc. Neurosci. Abstr. 19: 425.
158. 158 BARRETT‐CONNOR, E. & D. KRITZ‐SILVERSTEIN 1993. Estrogen replacement therapy and cognitive function in older women. JAMA 269: 2637–2641.
159. 159 YANASE, M., A. HONMURA, T. AKAISHI & Y. SAKUMA 1988. Nerve growth factor‐mediated sexual differentiation of the rat hypothalamus. Neurosci. Res. 6: 181–185.
160. 160 HASEGAWA, N., T. TAKEO & Y. SAKUMA 1991. Differential regulation of estrogen‐dependent sexual development of rat brain by growth factors. Neurosci. Lett. 123: 183–186.
161. 161 GIBBS, R. B., M. M. MCCARTHY & D. W. PFAFF 1993. Nerve growth factor affects defense‐related behaviors, but not lordosis, in ovariectomized, estrogen‐treated rats. Brain Res. 610: 256–266.
162. 162 NISHIZUKA, M., R. KATOH‐SEMBRA, K. ETO, Y. ARAI, R. IIZUKA & K. KATO 1991. Age‐ and sex‐related differences in the nerve growth factor distribution in the rat brain. Brain Res. Bull. 27: 685–688.
163. 163 GIBBS, R. B., J. T. MCCABE, C. R. BUCK, M. V. CHAO & D. W. PFAFF 1989. Expression of NGF receptor in the rat forebrain detected with in situ hybridization and immunohistochemistry. Mol. Brain Res. 6: 275–287.
164. 164 KOH, S., G. A. OYLER & G. A. HIGGINS 1989. Localization of nerve growth factor receptor messenger RNA and protein in the adult rat brain. Exp. Neurol. 106: 209–221.
165. 165 RAIVICH, G. & G. W. KREUTZBERG 1987. The localization and distribution of high affinity β‐nerve growth factor binding sites in the central nervous system of the adult rat. A light microscopic autoradiographic study using [ 125 l]β‐nerve growth factor. Neuroscience 20: 23–36.
166. 166 RICHARDSON, P. M., V. M. K. V. ISSA & R. J. RIOPELLE 1986. Distribution of neuronal receptors for nerve growth factor in the rat. J Neurosci. 6: 2312–2321.
167. 167 PIORO, E. P. & A. C. CUELLO 1990. Distribution of nerve factor receptor‐like growth immunoreactivity in the adult rat central nervous system. Effect of colchicine and correlation with the cholinergic system—I. Forebrain. Neurosci. 34: 57–7.
168. 168 PIORO, E. P. & A. C. CUELLO 1990. Distribution of nerve growth factor receptor‐like immunoreactivity in the adult rat central nervous system. Effect of colchicine and correlation with the cholinergic system—II. Brainstem, cerebellum and spinal cord. Neuroscience 34: 89–110.